Selection of the treatment strategies of myelodysplastic syndromes based on clone category
10.3760/cma.j.issn.1009-9921.2011.12.019
- VernacularTitle:不同克隆类型骨髓增生异常综合征治疗方法的选择
- Author:
Xiaomei HU
;
Junli MA
- Publication Type:Journal Article
- Keywords:
Myelodysplastic syndromes;
Cloning,molecular;
Therapy
- From:
Journal of Leukemia & Lymphoma
2011;20(12):759-762
- CountryChina
- Language:Chinese
-
Abstract:
Myelodysplastic syndromes(MDS) are heterogeneous clonal stem cell disorders.There are about 40 ％-60 ％ MDS patients with abnormal karyotype.To analyze the clone category is not only useful for diagnosis and evaluating prognosis,but also helpful for the selection of optimal therapy strategies to improve the treatment efficacy.
